CVA Family Office’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.4K Buy
257
+40
+18% +$9.95K 0.01% 545
2025
Q4
$59.7K Sell
217
-2
-0.9% -$547 0.01% 528
2025
Q3
$57.5K Buy
219
+17
+8% +$4.13K 0.01% 528
2025
Q2
$44.2K Buy
202
+172
+573% +$36.8K 0.01% 566
2025
Q1
$6.72K Sell
30
-36
-55% -$9.92K ﹤0.01% 861
2024
Q4
$21.6K Buy
66
+54
+450% +$17K ﹤0.01% 662
2024
Q3
$3.6K Sell
12
-12
-50% -$3.67K ﹤0.01% 893
2024
Q2
$7.91K Buy
24
+3
+14% +$1.06K ﹤0.01% 772
2024
Q1
$8.31K Buy
21
+1
+5% +$370 ﹤0.01% 768
2023
Q4
$7.04K Buy
+20
New +$7.08K ﹤0.01% 772
2023
Q3
Sell
-25
Closed -$9.56K 964
2023
Q2
$9.56K Buy
25
+5
+25% +$1.79K ﹤0.01% 727
2023
Q1
$6.93K Buy
+20
New +$5.84K ﹤0.01% 734
2022
Q4
Sell
-45
Closed -$11K 1015
2022
Q3
$11K Sell
45
-25
-36% -$7.62K ﹤0.01% 618
2022
Q2
$21K Buy
70
+25
+56% +$8.13K 0.01% 535
2022
Q1
$18K Hold
45
﹤0.01% 589
2021
Q4
$21K Buy
+45
New +$19.4K 0.01% 522
2021
Q3
Sell
-63
Closed -$23K 896
2021
Q2
$23K Buy
63
+18
+40% +$5.95K 0.01% 506
2021
Q1
$13K Buy
+45
New +$12.9K ﹤0.01% 493

Other funds holding WST